193 related articles for article (PubMed ID: 3019354)
1. Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes.
Hurst NP; French JK; Bell AL; Nuki G; O'Donnell ML; Betts WH; Cleland LG
Biochem Pharmacol; 1986 Sep; 35(18):3083-9. PubMed ID: 3019354
[TBL] [Abstract][Full Text] [Related]
2. Phorbol 12-myristate 13-acetate, A23187 and L-adrenaline inhibit phospholipid methylation in human monocytes and lymphocytes. Inhibition is independent of oxyradical production and phospholipid hydrolysis.
French JK; Hurst NP; Betts WH
Free Radic Biol Med; 1990; 9(4):271-7. PubMed ID: 2178146
[TBL] [Abstract][Full Text] [Related]
3. Role of Ca2+ in phosphatidylinositol response and arachidonic acid release in formylated tripeptide- or Ca2+ ionophore A23187-stimulated guinea pig neutrophils.
Takenawa T; Homma Y; Nagai Y
J Immunol; 1983 Jun; 130(6):2849-55. PubMed ID: 6406597
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and hydroxychloroquine inhibit multiple sites in metabolic pathways leading to neutrophil superoxide release.
Hurst NP; French JK; Gorjatschko L; Betts WH
J Rheumatol; 1988 Jan; 15(1):23-7. PubMed ID: 2832600
[TBL] [Abstract][Full Text] [Related]
5. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
6. Effects of piroxicam on superoxide generation, phospholipid methylation and leukotriene production by human blood mononuclear cells.
French JK; Hurst NP; McColl SR; Cleland L
J Rheumatol; 1987 Oct; 14(5):1018-21. PubMed ID: 2828616
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine.
Hurst NP; French JK; Gorjatschko L; Betts WH
Ann Rheum Dis; 1987 Oct; 46(10):750-6. PubMed ID: 2825613
[TBL] [Abstract][Full Text] [Related]
8. Identification of distinct activation pathways of the human neutrophil NADPH-oxidase.
Maridonneau-Parini I; Tringale SM; Tauber AI
J Immunol; 1986 Nov; 137(9):2925-9. PubMed ID: 3020128
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of N-formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-induced arachidonic acid release in guinea pig alveolar macrophages: involvement of a GTP-binding protein and role of protein kinase A and protein kinase C.
Kadiri C; Cherqui G; Masliah J; Rybkine T; Etienne J; Béréziat G
Mol Pharmacol; 1990 Sep; 38(3):418-25. PubMed ID: 2119477
[TBL] [Abstract][Full Text] [Related]
10. FMLP-induced arachidonic acid release, phospholipid metabolism, and calcium mobilization in human monocytes. Regulation by cyclic AMP.
Godfrey RW; Manzi RM; Jensen BD; Hoffstein ST
Inflammation; 1988 Jun; 12(3):223-30. PubMed ID: 2458317
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
12. fMLP-induced arachidonic acid release in db-cAMP-differentiated HL-60 cells is independent of phosphatidylinositol-4, 5-bisphosphate-specific phospholipase C activation and cytosolic phospholipase A(2) activation.
Sternfeld L; Thévenod F; Schulz I
Arch Biochem Biophys; 2000 Jun; 378(2):246-58. PubMed ID: 10860542
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
14. Functional consequences of phospholipase A2 activation in human monocytes.
Hoffman T; Brando C; Lizzio EF; Lee C; Hanson M; Ting K; Kim YJ; Abrahamsen T; Puri J; Bonvini E
Adv Exp Med Biol; 1990; 279():125-36. PubMed ID: 1965768
[TBL] [Abstract][Full Text] [Related]
15. Role of enhanced inositol phospholipid metabolism in neutrophil activation.
Takenawa T; Ishitoya J; Homma Y; Kato M; Nagai Y
Biochem Pharmacol; 1985 Jun; 34(11):1931-5. PubMed ID: 2988563
[TBL] [Abstract][Full Text] [Related]
16. Increase of phosphatidylinositol arachidonic acid incorporation induced by mepacrine.
Sterin-Speziale NB; Setton CP; Kahane VL; Speziale EH
Biochem Pharmacol; 1989 Mar; 38(5):725-8. PubMed ID: 2495005
[TBL] [Abstract][Full Text] [Related]
17. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
Palmer RM; Salmon JA
Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid and arachidonic acid metabolism in zymosan-stimulated human monocytes: modulation by cAMP.
Godfrey RW; Manzi RM; Gennaro DE; Hoffstein ST
J Cell Physiol; 1987 Jun; 131(3):384-92. PubMed ID: 2439518
[TBL] [Abstract][Full Text] [Related]
19. Albumin in monocyte function assays. Differential stimulation of superoxide or arachidonate release by calcium ionophores.
Hoffman T; Lizzio EF
J Immunol Methods; 1988 Aug; 112(1):9-14. PubMed ID: 2841376
[TBL] [Abstract][Full Text] [Related]
20. Diclofenac inhibits monocyte superoxide production ex vivo in rheumatoid arthritis.
Bell AL; Adamson H; Kirk F; McCaigue MD; Rotman H
Rheumatol Int; 1991; 11(1):27-30. PubMed ID: 1650959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
